XML 39 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Jun. 30, 2020
Current assets:    
Cash and cash equivalents $ 1,891,500,000 $ 1,908,500,000
Accounts receivable, net of allowance for doubtful accounts of $83.1 and $92.5, respectively 2,765,400,000 2,441,300,000
Other current assets 604,500,000 506,200,000
Total current assets before funds held for clients 5,261,400,000 4,856,000,000.0
Funds held for clients 41,491,000,000.0 26,708,100,000
Total current assets 46,752,400,000 31,564,100,000
Long-term receivables, net of allowance for doubtful accounts of $0.5 and $0.5, respectively 12,900,000 18,600,000
Property, plant and equipment, net 701,400,000 703,900,000
Operating lease right-of-use asset 493,800,000 493,700,000
Deferred contract costs 2,425,500,000 2,401,600,000
Other assets 475,100,000 458,400,000
Goodwill 2,333,800,000 2,309,400,000
Intangible assets, net 1,212,800,000 1,215,800,000
Total assets 54,407,700,000 39,165,500,000
Current liabilities:    
Accounts payable 112,200,000 102,000,000.0
Accrued expenses and other current liabilities 2,000,900,000 1,980,700,000
Accrued payroll and payroll-related expenses 762,100,000 557,000,000.0
Dividends payable 392,700,000 387,300,000
Short-term deferred revenues 200,700,000 212,500,000
Obligations under reverse repurchase agreements [1] 0 13,600,000
Short-term debt 0 1,001,800,000
Income taxes payable 103,600,000 40,100,000
Total current liabilities before client funds obligations 3,572,200,000 4,295,000,000.0
Client funds obligations 41,043,000,000.0 25,831,600,000
Total current liabilities 44,615,200,000 30,126,600,000
Long-term debt 1,994,300,000 1,002,800,000
Operating lease liabilities 360,900,000 344,400,000
Other liabilities 806,500,000 837,000,000.0
Deferred income taxes 592,000,000.0 731,900,000
Long-term deferred revenues 364,900,000 370,600,000
Total liabilities 48,733,800,000 33,413,300,000
Commitments and contingencies (Note 13)
Stockholders' equity:    
Preferred stock, $1.00 par value: authorized, 0.3 shares; issued, none 0 0
Common stock, $0.10 par value: authorized, 1,000.0 shares; issued, 638.7 shares at March 31, 2021 and June 30, 2020; outstanding, 426.0 and 429.9 shares at March 31, 2021 and June 30, 2020, respectively 63,900,000 63,900,000
Capital in excess of par value 1,479,800,000 1,333,800,000
Retained earnings 19,307,500,000 18,436,300,000
Treasury stock - at cost: 212.7 and 208.9 shares at March 31, 2021 and June 30, 2020, respectively (14,919,600,000) (14,067,000,000.0)
Accumulated other comprehensive income (loss) (257,700,000) (14,800,000)
Total stockholders’ equity 5,673,900,000 5,752,200,000
Total liabilities and stockholders’ equity $ 54,407,700,000 $ 39,165,500,000
[1] As of June 30, 2020, $13.6 million of long-term marketable securities have been pledged as collateral under the Company's reverse repurchase agreements (see Note 9).